YARROW

Pharmaceutical products and preparations for central nervous system and ophthalmic diseases and disorders; genetic therapy products and preparations, namely, oligonucleotide therapies for central nervous system and ophthalmic diseases and disorders; biological products and preparations, namely, monoclonal antibodies, multi-specific antibodies, protein therapeutics, and cell-based therapeutics for central nervous system and ophthalmic diseases and disorders for medical use; all of the foregoing excluding dietary and nutritional supplements

Scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the fields of disease treatment and gene therapy; technological assessment, research, and development of medical devices, pharmaceutical products, gene therapies, and treatment modalities for a range of diseases